no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adjuvante Chemotherapie bei muskelinvasivem Blasenkarzinom (individuelle Patientendaten) - Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
|
Wilborn, D. |
|
2017 |
56 |
2 |
p. 237-240 |
article |
2 |
Candidurie! Was nun? - Candiduria! What now?
|
Hof, H. |
|
2016 |
56 |
2 |
p. 172-179 |
article |
3 |
Dank an die Gutachter
|
|
|
2017 |
56 |
2 |
p. 156 |
article |
4 |
DGU-Kongress, Hamburg und die Präsidentenmedaille - German Society of Urology Congress, Hamburg and the Presidential Medal
|
Albrecht, K. |
|
2016 |
56 |
2 |
p. 233-236 |
article |
5 |
Die GeSRU e. V. – eine Erfolgsgeschichte - GeSRU e. V. – a success story
|
Struck, J. P. |
|
2017 |
56 |
2 |
p. 245-246 |
article |
6 |
Fokale Dosiseskalation in der Therapie des Prostatakarzinoms - Focal dose escalation in the treatment of prostate cancer
|
Cordes, J. |
|
2016 |
56 |
2 |
p. 157-166 |
article |
7 |
Harnwegsinfekte bei Kindern - Urinary tract infections in children
|
Lellig, E. |
|
2017 |
56 |
2 |
p. 247-262 |
article |
8 |
Kortikoide im Management des fortgeschrittenen Prostatakarzinoms - Corticosteroids in the management of advanced prostate cancer
|
Kübler, H. |
|
2016 |
56 |
2 |
p. 217-223 |
article |
9 |
Mitteilungen der DGU
|
|
|
2017 |
56 |
2 |
p. 263-270 |
article |
10 |
Mitteilungen der DGU
|
|
|
2017 |
56 |
2 |
p. 280-290 |
article |
11 |
Mitteilungen des BDU
|
|
|
2017 |
56 |
2 |
p. 273-279 |
article |
12 |
Modernes Netzwerken - Modern networks
|
Hofbauer, S. |
|
2016 |
56 |
2 |
p. 202-207 |
article |
13 |
MRT/TRUS-fusionierte Biopsiesysteme - MRI/TRUS fusion-guided prostate biopsy
|
Franz, T. |
|
2016 |
56 |
2 |
p. 208-216 |
article |
14 |
Neurogene Detrusorhyperaktivität und Onabotulinumtoxin A (Botox®) - Neurogenic detrusor overactivity and onabotulinumtoxin A (Botox®)
|
Kaufmann, A. |
|
2017 |
56 |
2 |
p. 241-242 |
article |
15 |
Nicht muskelinvasives Harnblasenkarzinom: Risikostratifizierung und Befundweitergabe - Non-muscle-invasive bladder cancer: Information transfer from the clinic to the doctor’s office
|
Lebentrau, S. |
|
2016 |
56 |
2 |
p. 194-201 |
article |
16 |
Nitroxolin – eine Option zur antibiotischen Therapie von Harnwegsinfektionen - Nitroxoline – an option for the antibiotic treatment of urinary tract infections
|
Hof, H. |
|
2016 |
56 |
2 |
p. 167-171 |
article |
17 |
Phase-III-Studie beim lokalen oder lokal fortgeschrittenen Prostatakarzinom - Phase III study for local or locally advanced prostate cancer
|
Rexer, H. |
|
2017 |
56 |
2 |
p. 243-244 |
article |
18 |
PREFERE – Das Scheitern einer (fast) perfekten Studie - PREFERE – the failure of an (almost) perfect study
|
Klotz, T. |
|
2017 |
56 |
2 |
p. 231-232 |
article |
19 |
Soziale Unterstützung bei genitalangleichender Operation - Social support in gender reassignment surgery
|
Hess, J. |
|
2016 |
56 |
2 |
p. 186-193 |
article |
20 |
Urogynäkologische Eingriffe - Urogynecologycal surgery
|
Dettmeyer, R. |
|
2016 |
56 |
2 |
p. 224-230 |
article |
21 |
URO-Telegramm
|
|
|
2017 |
56 |
2 |
p. 271-272 |
article |
22 |
Wanderungsgeschwindigkeit von uropathogenen Erregern - Migration speed of uropathogens
|
Braunwarth, H. |
|
2016 |
56 |
2 |
p. 180-185 |
article |
23 |
Zum „Neustart“ der Zusammenarbeit - “Restarting” our collaboration
|
Schroeder, Axel |
|
2017 |
56 |
2 |
p. 155 |
article |